10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34137279 | Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID? | 2022 Mar | 1 |
2 | 35174529 | Tyrosine kinase inhibitors and direct oral anticoagulants: In vitro evaluation of drug-drug interaction mediated by P-glycoprotein. | 2022 Feb 16 | 2 |
3 | 32329770 | Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function. | 2020 Apr 1 | 1 |
4 | 32862668 | Drug-Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms. | 2020 Jan-Dec | 1 |
5 | 31113643 | Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs? | 2019 Sep | 1 |
6 | 31520256 | Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation. | 2019 Oct | 1 |
7 | 28895074 | In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition. | 2018 Apr | 2 |
8 | 29274758 | Efficacy and Safety Outcomes of Direct Oral Anticoagulants and Amiodarone in Patients with Atrial Fibrillation. | 2018 May | 2 |
9 | 29572341 | In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein. | 2018 Jun | 3 |
10 | 27893182 | Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. | 2017 Feb | 3 |